知镜 Cognispect · 医学文献与研究工作台

Circulating C-peptide as an independent predictor of HFpEF: influence of cardiometabolic risk beyond diabetes.

Longo S, Nucera A, Piciucchi G, Sulpizio A, Ferrazza G, Rinaldi T, Martina S, Quatrana A, Cardellini M, Rizza S, Federici M.
Acta diabetologica · 2026-08-21 · PMID 42627499

文献摘要

Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous syndromecharacterized by diastolic dysfunction, preserved left ventricular ejection fraction, and arange of myocardial structural and metabolic abnormalities1. Rather than representingan isolated cardiac disorder, HFpEF is increasingly recognized as a multisystemdisorder, driven by multiple comorbidities, and manifesting as diverse clinicalphenotypes defined by differences in comorbidity burden, disease severity, cardiacstructure, biomarkers, and prognosis. Metabolic comorbidities such as obesity,dyslipidemia, type 2 diabetes (T2D), and hypertension are highly prevalent in HFpEFand may define a distinct cardiometabolic HFpEF (cmHFpEF) phenotype, marked bymore severe symptoms and poorer quality of life2. The coexistence of metaboliccomorbidities drives multisystem pathophysiological changes, worsening prognosis,and limiting the effectiveness of current therapies3.This study aimed to investigate the pathophysiological mechanisms of HFpEF, with afocus on cardiometabolic risk burden as a major contributor to HFpEF phenotypicheterogeneity, to inform future phenotyping strategies and therapeutic approaches.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。